# US 2006/0154365 A1 · Cultured three dimensional tissues and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154365 A1
- Document ID: US20060154365A1
- Status: Published application
- Kind: A1
- Application number: 11/216,574
- Filed: 2005-08-30
- Published: 2006-07-13
- Earliest claimed: 2004-08-30
- Inventors: Anthony Ratcliffe; Jonathan Mansbridge; Lee Landeen; Emmett Pinney; Linette Edison
- Web page: https://patentgrep.com/patent/US20060154365A1

## CPC

- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 35/33: Fibroblasts
- A61K 35/36: Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39)
- A61K 38/18: Growth factors; Growth regulators
- A61K 38/1866: {Vascular endothelial growth factor [VEGF]}
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 27/3869: {Epithelial tissues other than skin}
- A61L 27/58: Materials at least partially resorbable by the body
- A61Q 7/00: Preparations for affecting hair growth
- C12N 5/0062: {General methods for three-dimensional culture}
- A61K 2800/91: Injection
- C12N 2501/415: Wnt; Frizzeled
- C12N 2502/1323: Adult fibroblasts
- C12N 2531/00: Microcarriers
- C12N 2533/40: Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present disclosure provides compositions of three dimensional tissue that can be administered into tissues and organs using minimally invasive methods. The three dimensional tissues elaborate a repertoire of growth factors that facilitate repair or regeneration of damaged tissues and organs.

## Claims

### Claim 1

A composition comprising:
a cultured three dimensional tissue dimensioned for or so dimensioned as to permit penetration into tissues, wherein the three dimensional tissue comprises a scaffold of a biocompatible, nonliving material.

### Claim 2 (depends on 1)

The composition of claim 1 in which the living cells comprise stromal cells.

### Claim 3 (depends on 2)

The composition of claim 2 in which the stromal cells comprise fibroblasts.

### Claim 4 (depends on 1)

The composition of claim 1 in which the livings cells comprise one or more of fibroblasts, smooth muscle cells, cardiac muscle cells, endothelial cells, pericytes, macrophages, monocytes, leukocytes, plasma cells, mast cells, or adipocytes.

### Claim 5 (depends on 1)

The composition of claim 1 in which the living cells comprise mesenchymal stem cells.

### Claim 6 (depends on 1)

The composition of claim 1 in which the scaffold comprises a population of microparticles.

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10 (depends on 6)

The composition of claim 6 in which the microparticles comprise a biodegradable material.

### Claim 11 (depends on 10)

The composition of claim 10 in which the biodegradable material is selected from polylactide, polyglycolic acid, polylactide-co-glycolic acid, trimethylene carbonate, and copolymers thereof in any combination and in any percent combination.

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20

(canceled)

### Claim 21

(canceled)

### Claim 22 (depends on 1)

The composition of claim 1 in which the scaffold comprises a network of nonwoven filaments that form a particulate when cultured with the living cells.

### Claim 23 (depends on 22)

The composition of claim 22 in which the network of nonwoven filaments comprises a felt.

### Claim 24 (depends on 22)

The composition of claim 22 in which the nowoven filaments comprise biodegradable filaments.

### Claim 25

(canceled)

### Claim 26 (depends on 1)

The composition of claim 1 in which the scaffold comprises woven filaments that form a cord with interstitial spaces.

### Claim 27 (depends on 26)

The composition of claim 26 in which the cord further comprises an internal luminal space formed by the woven filaments.

### Claim 28 (depends on 26)

The composition of claim 26 in which the filaments are woven into a braid.

### Claim 29

(canceled)

### Claim 30 (depends on 26)

The composition of claim 26 in which the woven filaments comprise one or more biodegradable filaments.

### Claim 31

(canceled)

### Claim 32 (depends on 26)

The composition of claim 26 in which the scaffold is suitable for use as a surgical suture.

### Claim 33

(canceled)

### Claim 34

(canceled)

### Claim 35

(canceled)

### Claim 36 (depends on 1)

A method of treating damaged tissue, comprising:
administering the cell culture composition of claim 1 in an amount effective to facilitate repair or regeneration of the damaged tissue.

### Claim 37 (depends on 36)

The method of claim 36 in which the administration is by injection.

### Claim 38 (depends on 36)

The method of claim 36 in which the administration is by a catheter.

### Claim 39 (depends on 36)

The method of claim 36 in which the damaged tissue is an ischemic tissue.

### Claim 40 (depends on 39)

The method of claim 39 in which the ischemic tissue is at least one of skeletal muscle, cardiac muscle, smooth muscle, or skin.

### Claim 41

(canceled)

### Claim 42

(canceled)

### Claim 43

(canceled)

### Claim 44

(canceled)

### Claim 45

(canceled)

### Claim 46

(canceled)

### Claim 47

(canceled)

### Claim 48

(canceled)

### Claim 49

(canceled)

### Claim 50

(canceled)

### Claim 51

(canceled)

### Claim 52

(canceled)

### Claim 53

(canceled)

### Claim 54

(canceled)

### Claim 55

(canceled)

### Claim 56

(canceled)

### Claim 57

(canceled)

### Claim 58

(canceled)

### Claim 59

(canceled)

### Claim 60

(canceled)

### Claim 61

(canceled)

### Claim 62

(canceled)

### Claim 63

(canceled)

### Claim 64

(canceled)

### Claim 65

(canceled)

### Claim 66

(canceled)

### Claim 67

(canceled)

### Claim 68

(canceled)

### Claim 69

(canceled)

### Claim 70 (depends on 32)

A method of facilitating healing of anastomoses, comprising: applying the surgical suture of claim 32 in forming the anastomotic site.

### Claim 71 (depends on 70)

The method of claim 70 in which the anastomosis is from a vascular graft.

### Claim 72

(canceled)

### Claim 73

(canceled)

### Claim 74

(canceled)

### Claim 75

(canceled)
